Literature DB >> 2035255

Morphological typing of chondrosarcoma: a study of 94 cases.

H Welkerling1, T Dreyer, G Delling.   

Abstract

Ninety-four chondrosarcomas of the Hamburg Bone Tumour Registry were reviewed in a retrospective study. The purpose of this study was to examine the morphological characteristics of different types of chondrosarcomas and to describe distinctive features of location, the age distribution and the male to female ratio. Central chondrosarcomas can be divided into classical chondrosarcomas, dedifferentiated chondrosarcomas, mesenchymal chondrosarcomas and clear-cell chondrosarcomas. Five periosteal chondrosarcomas were represented. Classical chondrosarcomas and clear-cell chondrosarcomas show a significant predominance of males; no sex predilection was seen in dedifferentiated and mesenchymal chondrosarcomas. Nearly 60% of classical and mesenchymal chondrosarcomas occur in the trunk. Eighty-five percent of dedifferentiated chondrosarcomas are located in the long bones of the limbs. Clear-cell chondrosarcomas arise in the proximal part of the femur. There is a marked predilection for mesenchymal chondrosarcomas in the second and third decades of life. The average age of patients with classical chondrosarcomas was 54 years, but clear-cell chondrosarcomas occur 10 years earlier and dedifferentiated chondrosarcomas 10 years later. Characteristically, classical chondrosarcomas produce a pure chondroid matrix with variable differentiation of tumour chondrocytes. The most important histological feature of the defifferentiated chondrosarcoma is the close association of two different cellular components. One of these consists of cartilage, which is generally well differentiated. In most of our cases the second component showed features of osteosarcoma (50%). Mesenchymal chondrosarcoma is characterized by concentric infiltration of cartilage islands by small tumour cells. Clear-cell chondrosarcomas show regions of cartilaginous tumour and areas of closely packed, glycogen-rich, large tumour cells with distinct boundaries. Osteoid formation and multinucleated giant cells are present in clear-cell areas. Knowledge of this group of tumours is indispensable for correct histological diagnosis and typing and is important in the design of surgical therapy and the prediction of biological behaviour.

Entities:  

Mesh:

Year:  1991        PMID: 2035255     DOI: 10.1007/bf01605928

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  27 in total

1.  MESENCHYMAL CHONDROSARCOMA.

Authors:  E A DOWLING
Journal:  J Bone Joint Surg Am       Date:  1964-06       Impact factor: 5.284

2.  Mesenchymal chondrosarcoma. Further observations on a new entity.

Authors:  D C DAHLIN; E D HENDERSON
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

3.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

4.  Chondrosarcoma: clear-cell variant. A report of sixteen cases.

Authors:  K K Unni; D C Dahlin; J W Beabout; F H Sim
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

Review 5.  Clear cell chondrosarcoma. Report of a new case and review of the literature.

Authors:  R Volpe; A Mazabraud; J P Thiery
Journal:  Pathologica       Date:  1983 Nov-Dec

6.  [Clear cell chondrosarcoma--clinico-pathological report of an additional case].

Authors:  H Welkerling; T Dreyer; B Hermann; D Steiner; G Delling
Journal:  Z Orthop Ihre Grenzgeb       Date:  1990 Nov-Dec

7.  A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases.

Authors:  J M Mirra; R Gold; J Downs; J J Eckardt
Journal:  Clin Orthop Relat Res       Date:  1985-12       Impact factor: 4.176

8.  The management of chondrosarcoma of bone.

Authors:  A I Eriksson; A Schiller; H J Mankin
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

9.  Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment.

Authors:  A G Huvos; G Rosen; M Dabska; R C Marcove
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

10.  Mesenchymal chondrosarcoma: a report of 17 cases.

Authors:  A R Harwood; J I Krajbich; V L Fornasier
Journal:  Clin Orthop Relat Res       Date:  1981 Jul-Aug       Impact factor: 4.176

View more
  6 in total

Review 1.  [Musculoskeletal tumors: significance of morphological diagnostics].

Authors:  M Werner; K Hauptmann; C H Lohmann; G Jundt
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

2.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

Review 3.  Tracheal chondrosarcoma.

Authors:  Vera Mendonça; Marília Jorge; Isabel Monteiro-Grillo; Maria João Palhano; Salvato Feijó
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

4.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

5.  Differentiating high-grade from low-grade chondrosarcoma with MR imaging.

Authors:  Hye Jin Yoo; Sung Hwan Hong; Ja-Young Choi; Kyung Chul Moon; Han-Soo Kim; Jung-Ah Choi; Heung Sik Kang
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

6.  Successful chemoradiation therapy for high-grade skull base chondrosarcoma in a child.

Authors:  T Yoshimoto; Y Sawamura; J Ikeda; N Ishii; H Abe
Journal:  Childs Nerv Syst       Date:  1995-04       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.